论文部分内容阅读
随着顺式二氯二氨铂 (DDP)临床应用中毒性和耐药性等问题的出现 ,2 0多年来不断深入研究合成了 3 0 0 0多个新铂配合物。其中有 2 8个进入临床试验 ,但至今只有DDP、卡铂、奈达铂、丙二酸铂和草酸铂获得批准成为正式产品上市 ,1 8个配合物因活性低或毒性大而被放弃。目前还有 5个铂配合物正处于临床研究的不同阶段。
With the emergence of toxicity and drug resistance problems in the clinical application of cis-dichloro-dichloroplatinum (DDP), over 300 years of continuous research and synthesis of more than 300 new platinum complexes. Of these, 28 have entered clinical trials, but so far only DDP, carboplatin, nedaplatin, platinum malonate, and oxaliplatin have been approved as official products, and 18 complexes have been abandoned because of low activity or toxicity. There are currently five platinum complexes that are at different stages of clinical research.